The Benefit of Adjuvant Radiation in Surgically-Treated T1-2 N1 Oropharyngeal Squamous Cell Carcinoma.
Autorzy:
Monroe MM; Departments of Otolaryngology-Head and Neck Surgery, University of Utah School of Medicine Salt Lake City Utah U.S.A.; Huntsman Cancer Institute, University of Utah School of Medicine Salt Lake City Utah U.S.A. Buchmann LO; Departments of Otolaryngology-Head and Neck Surgery, University of Utah School of Medicine Salt Lake City Utah U.S.A.; Huntsman Cancer Institute, University of Utah School of Medicine Salt Lake City Utah U.S.A. Hunt JP; Departments of Otolaryngology-Head and Neck Surgery, University of Utah School of Medicine Salt Lake City Utah U.S.A.; Huntsman Cancer Institute, University of Utah School of Medicine Salt Lake City Utah U.S.A. Hitchcock YJ; Radiation Oncology, University of Utah School of Medicine Salt Lake City Utah U.S.A.; Huntsman Cancer Institute, University of Utah School of Medicine Salt Lake City Utah U.S.A. Lloyd S; Radiation Oncology, University of Utah School of Medicine Salt Lake City Utah U.S.A.; Huntsman Cancer Institute, University of Utah School of Medicine Salt Lake City Utah U.S.A. Hashibe M; Family and Preventative Medicine, Division of Public Health, University of Utah School of Medicine Salt Lake City Utah U.S.A.; Huntsman Cancer Institute, University of Utah School of Medicine Salt Lake City Utah U.S.A.
Pokaż więcej
Źródło:
Laryngoscope investigative otolaryngology [Laryngoscope Investig Otolaryngol] 2017 Feb 02; Vol. 2 (2), pp. 57-62. Date of Electronic Publication: 2017 Feb 02 (Print Publication: 2017).
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
